Volatile anesthetics in preventing acute kidney injury after cardiac surgery: A systematic review and meta-analysis

Journal of Thoracic and Cardiovascular Surgery

Volumn 148, Issue 6, 2014, Pages 3127-3136

  Cai, Jieru ^a,b   Xu, Rende ^a   Yu, Xiaofang ^a,b,c   Fang, Yi ^a,b,c   Ding, Xiaoqiang ^a,b,c  

^a FUDAN UNIVERSITY   (China)

^b Kidney and Dialysis Institute of Shanghai   (China)

^c Kidney and Blood Purification Laboratory of Shanghai   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DESFLURANE; MIDAZOLAM; PROPOFOL; SEVOFLURANE; SUFENTANIL; BIOLOGICAL MARKER; INHALATION ANESTHETIC AGENT;

ACUTE KIDNEY FAILURE; CLINICAL EFFECTIVENESS; COCHRANE LIBRARY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; EMBASE; FEMALE; HEART SURGERY; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; INTRAVENOUS ANESTHESIA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDLINE; META ANALYSIS (TOPIC); QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; RENAL REPLACEMENT THERAPY; REVIEW; SURGICAL MORTALITY; SURGICAL PATIENT; SYSTEMATIC REVIEW (TOPIC); ACUTE KIDNEY INJURY; BLOOD; CHI SQUARE DISTRIBUTION; DRUG EFFECTS; KIDNEY; META ANALYSIS; MORTALITY; PATHOPHYSIOLOGY; PROTECTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; RISK FACTOR; TIME; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; ANESTHETICS, INHALATION; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; CHI-SQUARE DISTRIBUTION; CREATININE; HOSPITAL MORTALITY; HUMANS; KIDNEY; LENGTH OF STAY; ODDS RATIO; PROTECTIVE FACTORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84920162787     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2014.07.085     Document Type: Article

References (38)

1. M.H. Rosner, and M.D. Okusa Acute kidney injury associated with cardiac surgery Clin J Am Soc Nephrol 1 2006 19 32
2. A. Shaw Update on acute kidney injury after cardiac surgery J Thorac Cardiovasc Surg 143 2012 676 681
3. J.L. Koyner, M.R. Bennett, E.M. Worcester, Q. Ma, J. Raman, and V. Jeevanandam Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery Kidney Int 74 2008 1059 1069
4. Y. Fang, X. Ding, Y. Zhong, J. Zou, J. Teng, and Y. Tang Acute kidney injury in a Chinese hospitalized population Blood Purif 30 2010 120 126
5. N. Mitter, A. Shah, D. Yuh, J. Dodd-O, R.E. Thompson, and D. Cameron Renal injury is associated with operative mortality after cardiac surgery for women and men J Thorac Cardiovasc Surg 140 2010 1367 1373
6. J.V. Bonventre, and A. Zuk Ischemic acute renal failure: an inflammatory disease? Kidney Int 66 2004 480 485
7. R. Bellomo, S. Auriemma, A. Fabbri, A. D'Onofrio, N. Katz, and P.A. McCullough The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI) Int J Artif Organs 31 2008 166 178
8. G. Landoni, G.G. Biondi-Zoccai, A. Zangrillo, E. Bignami, S. D'Avolio, and C. Marchetti Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials J Cardiothorac Vasc Anesth 21 2007 502 511
9. G. Minguet, J. Joris, and M. Lamy Preconditioning and protection against ischaemia-reperfusion in non-cardiac organs: a place for volatile anaesthetics? Eur J Anaesthesiol 24 2007 733 745
10. G. Landoni, E. Bignami, F. Oliviero, and A. Zangrillo Halogenated anaesthetics and cardiac protection in cardiac and non-cardiac anaesthesia Ann Card Anaesth 12 2009 4 9
11. M. Zaugg, E. Lucchinetti, M. Uecker, T. Pasch, and M.C. Schaub Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms Br J Anaesth 91 2003 551 565
12. G. Landoni, O. Fochi, and G. Torri Cardiac protection by volatile anaesthetics: a review Curr Vasc Pharmacol 6 2008 108 111
13. M. Kim, S.W. Park, M. Kim, V.D. D'Agati, and H.T. Lee Isoflurane activates intestinal sphingosine kinase to protect against renal ischemia-reperfusion-induced liver and intestine injury Anesthesiology 114 2011 363 373
14. 1 pathway Am J Physiol Renal Physiol 295 2008 F128 F136
15. P. Jia, J. Teng, J. Zou, Y. Fang, X. Zhang, and Z.J. Bosnjak miR-21 contributes to xenon-conferred amelioration of renal ischemia-reperfusion injury in mice Anesthesiology 119 2013 621 630
16. K. Julier, R. da Silva, C. Garcia, L. Bestmann, P. Frascarolo, and A. Zollinger Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study Anesthesiology 98 2003 1315 1327
17. W. Sindhvananda, K. Phisaiphun, and P. Prapongsena No renal protection from volatile-anesthetic preconditioning in open heart surgery J Anesth 27 2013 48 55
18. P. Jüni, D.G. Altman, and M. Egger Systematic reviews in health care: assessing the quality of controlled clinical trials BMJ 323 2001 42 46
19. S.P. Hozo, B. Djulbegovic, and I. Hozo Estimating the mean and variance from the median, range, and the size of a sample BMC Med Res Methodol 5 2005 13
20. E. Bignami, G. Landoni, C. Gerli, V. Testa, A. Mizzi, and G. Fano Sevoflurane vs. propofol in patients with coronary disease undergoing mitral surgery: a randomised study Acta Anaesthesiol Scand 56 2012 482 490
21. E.J. Cho, J.H. Yoon, S.J. Hong, S.H. Lee, and S.B. Sim The effects of sevoflurane on systemic and pulmonary inflammatory responses after cardiopulmonary bypass J Cardiothorac Vasc Anesth 23 2009 639 645
22. S.G. De Hert, P.J. Van der Linden, S. Cromheecke, R. Meeus, P.W. ten Broecke, and I.G. De Blier Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass Anesthesiology 101 2004 9 20
23. F. Guarracino, G. Landoni, L. Tritapepe, F. Pompei, A. Leoni, and G. Aletti Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study J Cardiothorac Vasc Anesth 20 2006 477 483
24. M. Jovic, A. Stancic, D. Nenadic, O. Cekic, D. Nezic, and P. Milojevic Mitochondrial molecular basis of sevoflurane and propofol cardioprotection in patients undergoing aortic valve replacement with cardiopulmonary bypass Cell Physiol Biochem 29 2012 131 142
25. G. Landoni, M.G. Calabrò, C. Marchetti, E. Bignami, A.M. Scandroglio, and E. Dedola Desflurane versus propofol in patients undergoing mitral valve surgery J Cardiothorac Vasc Anesth 21 2007 672 677
26. S. Lorsomradee, S. Cromheecke, S. Lorsomradee, and S.G. De Hert Effects of sevoflurane on biomechanical markers of hepatic and renal dysfunction after coronary artery surgery J Cardiothorac Vasc Anesth 20 2006 684 690
27. D.A. Story, S. Poustie, G. Liu, and P.L. McNicol Changes in plasma creatinine concentration after cardiac anesthesia with isoflurane, propofol, or sevoflurane: a randomized clinical trial Anesthesiology 95 2001 842 848
28. L. Tritapepe, G. Landoni, F. Guarracino, F. Pompei, M. Crivellari, and D. Maselli Cardiac protection by volatile anaesthetics: a multicentre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass Eur J Anaesthesiol 24 2007 323 331
29. T. Swyers, D. Redford, and D.F. Larson Volatile anesthetic-induced preconditioning Perfusion 29 2014 10 15
30. N.R. Gravel, N.R. Searle, J. Taillefer, M. Carrier, M. Roy, and L. Gagnon Comparison of the hemodynamic effects of sevoflurane anesthesia induction and maintenance vs TIVA in CABG surgery Can J Anaesth 46 1999 240 246
31. E. Borthwick, and A. Ferguson Perioperative acute kidney injury: risk factors, recognition, management, and outcomes BMJ 341 2010 c3365
32. M. Schetz, T. Bove, A. Morelli, S. Mankad, C. Ronco, and J.A. Kellum Prevention of cardiac surgery-associated acute kidney injury Int J Artif Organs 31 2008 179 189
33. B. Cuhaci More data on epidemiology and outcome of acute kidney injury with AKIN criteria: benefits of standardized definitions, AKIN and RIFLE classifications Crit Care Med 37 2009 2659 2661
34. J.R. Brown, R.P. Cochran, L.J. Dacey, C.S. Ross, K.S. Kunzelman, and R.F. Dunton Perioperative increases in serum creatinine are predictive of increased 90-day mortality after coronary artery bypass graft surgery Circulation 114 1 Suppl 2006 I409 I413
35. A. Falvo, H.M. Horst, I. Rubinfeld, D. Blyden, M.M. Brandt, and J. Jordan Acute renal failure in cardiothoracic surgery patients: what is the best definition of this common and potent predictor of increased morbidity and mortality Am J Surg 196 2008 379 383
36. O.F. Laterza, C.P. Price, and M.G. Scott Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 48 2002 699 707
37. H.T. Lee, A. Ota-Setlik, Y. Fu, S.H. Nasr, and C.W. Emala Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo Anesthesiology 101 2004 1313 1324
38. B. Preckel, W. Schlack, T. Comfère, D. Obal, H. Barthel, and V. Thamer Effects of enflurane, isoflurane, sevoflurane and desflurane on reperfusion injury after regional myocardial ischaemia in the rabbit heart in vivo Br J Anaesth 81 1998 905 912